Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Tilleke & GibbinsWongrat Ratanaprayul of Tilleke & Gibbins highlights the complex processes required to secure AI patents across Southeast Asia -
Sponsored by Wanhuida Intellectual PropertyHonghui Hu of Wanhuida Intellectual Property explains that a CNIPA ruling on a patent covering an antidepressant could help to determine the patentability of pharmaceutical compounds
-
Sponsored by Maiwald Intellectual PropertyGisela Grabow of Maiwald considers the potential changes to the EU’s general pharmaceutical legislation under a recent proposal, and the main questions raised for stakeholders
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law reports on South Korea’s bid to lead the way on autonomous vehicles with a streamlined patent process.
-
Sponsored by Tilleke & GibbinsLoc Xuan Le of Tilleke & Gibbins reviews two thought-provoking Vietnamese IP cases, with potentially far-reaching implications for the country’s IP enforcement system.
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Shipra Alisha Philip of RNA Technology and IP Attorneys underline the importance of trademark protection in a booming nutraceuticals market in India and explain what steps brand owners should take
